Earlier this year, the National Association of Professional Employer Organizations (NAPEO) and the Florida Association of Professional Employer Organizations (FAPEO) hosted the Mike Miller Gala benefitting CureSearch for Children’s Cancer. The event took place at the Dali Museum in St. […]
The Mike Miller Honorary Gala Benefitting CureSearch Read More »
When Molly Lambert of Omaha was diagnosed with Acute Myeloid Leukemia (AML) at age 6, she was too young to understand the scope of what was happening and how drastically her life would change over the course of the next
Molly Lambert, Acute Myeloid Leukemia (AML) Read More »
CureSearch is grateful to have partnered with Kiewit Corporation over the past 11 years. Together, we raise critical funds for children’s cancer research. Kiewit’s contribution is already making major strides in the fight to end childhood cancer. In 2017, Kiewit
CureSearch Partner Raised Record Setting Amount in Memory of Jake Read More »
(charities.org) – “Your child has cancer” – it’s the worst news a parent can hear. For some families, this heartbreaking news comes just months after their son’s or daughter’s birth – like in the case of little 2-month old Ava.
Superheroes Unite to Protect the Future of Children Diagnosed with Cancer Read More »
Parker Institute researchers at Stanford create data-driven method to more accurately predict relapse at time of diagnosis (parkerici.org) – Parker Institute for Cancer Immunotherapy researchers at Stanford University School of Medicine have developed a better way to test early on
Predicting Childhood Leukemia Relapse Using Machine Learning Read More »
(loveyourmelon.com) – Ashleigh was just 19 years old when she was diagnosed with stage four osteosarcoma – a type of bone cancer. Battling an extremely aggressive cancer, Ashleigh and her family would spend days at the hospital hoping for the
17 Years Old at Diagnosis Patrick was a normal 17 year-old high school senior when he was diagnosed with stage 3 Non-Hodgkin t-cell lymphoma in September, 2006. After two months of treatment, Patrick’s immune system was depleted and he developed
Patrick Betters, Non-Hodgkin T-Cell Lymphoma Read More »
